| Injury mechanism | p-value | ||
---|---|---|---|---|
Blunt (n = 44) | Surgical (n = 14) | Total (n = 58) | ||
Sex (male: female) | 36: 8 | 9: 5 | 45: 13 | 0.141 |
Age (years) | 33.4 ± 16.7 (33) | 52.7 ± 15.6 (52) | 47.4 ± 15.6 (42) | < 0.001 |
Steroid treatment (yes: no) | 32: 12 | 12: 2 | 44: 14 | 0.134 |
Traumatic eye | Â | Â | Â | Â |
 Visual acuity  (LogMAR) | 1.35 ± 1.05 (1.3) | 1.38 ± 1.75 (1.3) | 1.36 ± 0.29 (1.3) | 0.769 |
 VFI (%) | 16.16 ± 5.51 (16) | 13.81 ± 7.72 (14) | 15.31 ± 6.37 (15) | 0.232 |
 RNFL thickness (µm) | 96.44 ± 9.17 (95) | 93.91 ± 10.92 (94) | 95.32 ± 7.11 (94) | 0.262 |
 GCIPL thickness (µm) | 68.44 ± 13.17 (69) | 63.91 ± 12.92 (65) | 65.22 ± 9.82 (67) | 0.176 |
 CD ratio | 0.62 ± 0.11 (0.6) | 0.57 ± 0.15 (0.6) | 0.61 ± 0.11 (0.6) | 0.723 |
Fellow eye | Â | Â | Â | Â |
 Visual acuity  (LogMAR) | 0.25 ± 0.18 (0.22) | 0.31 ± 0.28 (0.39) | 0.29 ± 0.17 (0.30) | 0.263 |
 VFI (%) | 88.35 ± 2.67 (89) | 93.38 ± 4.87 (91) | 90.33 ± 2.57 (90) | 0.551 |
 RNFL thickness (µm) | 99.33 ± 6.07 (98) | 95.78 ± 10.58 (96) | 97.82 ± 7.48 (97) | 0.701 |
 GCIPL thickness (µm) | 79.32 ± 4.07 (79) | 75.08 ± 4.58 (75) | 77.11 ± 2.44 (78) | 0.064 |
 CD ratio | 0.53 ± 0.08 (0.5) | 0.58 ± 0.13 (0.5) | 0.56 ± 0.07 (0.5) | 0.938 |